IP Library Granted Patent US 12,064,529
Granted Patent B2
US 12,064,529 · App. 17/056,352 · Granted Aug 20, 2024

Partially cured contact lens-type amniotic membrane dressing and method of manufacturing same

Inventor: Hong Kyun Kim (Daegu, KR)
Assignees: Kyungpook National University Industry-Academic Cooperation Foundation; Kyungpook National University Hospital
A61L27/3604A61L27/3666A61L27/3687A61L27/3691A61L2300/414A61L2430/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,064,529
App. No.
17/056,352
Granted
Aug 20, 2024
Kind
B2
Abstract

The present invention relates to a contact lens-type dressing manufactured by using a partially cured amniotic membrane dressing and a method of manufacturing same. The method of manufacturing a partially cured contact lens-type amniotic membrane dressing, and the partially cured contact lens-type amniotic membrane dressing of the present invention have a simple manufacturing method, can produce a contact lens-type amniotic membrane without foreign matter, have excellent biocompatibility, have excellent lens compatibility such as transparency and tensile strength compared to a fully cured contact lens-type amniotic membrane dressing, and also have excellent wound healing effects, and therefore, can be effectively used for the treatment of eye diseases such as corneal damage.

Claims (6)

1. A partially cured contact lens-type amniotic membrane dressing characterized in that a peripheral portion of the amniotic membrane is all cured such that the whole contact lens-type amniotic membrane is partially cured

wherein the peripheral portion of the amniotic membrane extends from an edge of the amniotic membrane to a point of ½ of a distance from the edge to a center of the amniotic membrane,

wherein the partially cured contact lens-type amniotic membrane dressing has increased growth factor secretion ability compared to a fully cured contact lens-type amniotic membrane dressing.

2. The partially cured contact lens-type amniotic membrane dressing of claim 1 , wherein the partially cured contact lens-type amniotic membrane dressing has a tensile strength greater by 2 to 4 times than a tensile strength of an amniotic membrane without treatment with a crosslinking agent.

3. The partially cured contact lens-type amniotic membrane dressing of claim 1 , wherein the partially cured contact lens-type amniotic membrane dressing is used for treatment of ocular diseases.

4. The partially cured contact lens-type amniotic membrane dressing of claim 1 , wherein the partially cured contact lens-type amniotic membrane dressing is used for treating ocular wounds.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2021
From: KIM, HONG KYUN
To: KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION; KYUNGPOOK NATIONAL UNIVERSITY HOSPTIAL
Reel/Frame 055780/0676 →
Priority Claims (1)
KR 10-2018-0056479 · May 17, 2018 · national
Continuity (1)
Related Publication 20210205496A1 · Jul 8, 2021